RUBICON RESEARCH
Smallcap | BSE
Sector
Index
Here's the live share price of Rubicon Research along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.73₹ 7.00
As on May 15, 2026, 04:01 PM IST
Rubicon Research Price Performance
Today's LowToday's High
₹954.55₹981.25
₹962.55
52 Weeks' Low52 Weeks' High
₹571.00₹1,019.10
₹962.55
Open Price
₹970.80
Prev. Close
₹955.55
Volume
8,842
Rubicon Research Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Rubicon Research | 0.82 | 16.74 | 21.29 | 29.37 | 53.41 | 15.33 | 8.94 |
| Sun Pharmaceutical Industries | 1.76 | 10.80 | 10.60 | 6.59 | 8.06 | 25.42 | 22.30 |
| Divi's Laboratories | 0.69 | 9.36 | 9.77 | 3.55 | 8.78 | 27.27 | 10.81 |
| Torrent Pharmaceuticals | 0.13 | 5.53 | 2.95 | 14.91 | 34.31 | 38.04 | 25.98 |
| Cipla | 6.22 | 16.70 | 5.59 | -6.82 | -4.71 | 15.76 | 10.19 |
| Dr. Reddy's Laboratories | 3.38 | 9.74 | 5.33 | 7.43 | 8.27 | 13.95 | 4.95 |
| Lupin | -4.37 | -2.79 | 2.40 | 10.83 | 9.78 | 42.42 | 13.85 |
| Mankind Pharma | 3.29 | 18.11 | 20.41 | 11.68 | -2.08 | 21.87 | 11.98 |
| Zydus Lifesciences | 7.71 | 8.04 | 11.13 | 8.24 | 11.81 | 25.00 | 10.58 |
| Aurobindo Pharma | 1.52 | 9.86 | 27.53 | 22.14 | 24.17 | 35.05 | 8.56 |
| Laurus Labs | 7.73 | 18.58 | 30.77 | 29.56 | 119.24 | 62.04 | 22.88 |
| Biocon | 13.01 | 22.71 | 13.10 | 2.08 | 27.03 | 20.17 | 2.20 |
| Alkem Laboratories | -1.78 | -1.77 | -0.05 | -4.29 | 3.54 | 17.03 | 12.94 |
| Glenmark Pharmaceuticals | -1.85 | 2.68 | 14.24 | 24.39 | 60.47 | 56.22 | 30.89 |
| Abbott India | 4.87 | 7.66 | 6.22 | -5.55 | -7.94 | 9.63 | 11.50 |
| Anthem Biosciences | -0.33 | 7.24 | 13.60 | 17.51 | 7.07 | 2.30 | 1.38 |
| GlaxoSmithKline Pharmaceuticals | -1.74 | 1.46 | -6.04 | -2.00 | -15.19 | 24.01 | 9.97 |
| Ipca Laboratories | 4.20 | 9.88 | 7.80 | 10.53 | 14.87 | 32.51 | 8.22 |
| Ajanta Pharma | 4.21 | 9.41 | 7.40 | 26.23 | 21.67 | 35.49 | 19.32 |
| J B Chemicals & Pharmaceuticals | -1.01 | 7.69 | 7.70 | 16.90 | 29.93 | 27.70 | 25.39 |
Over the last one year, Rubicon Research has gained 53.41% compared to peers like Sun Pharmaceutical Industries (8.06%), Divi's Laboratories (8.78%), Torrent Pharmaceuticals (34.31%). From a 5 year perspective, Rubicon Research has underperformed peers relative to Sun Pharmaceutical Industries (22.30%) and Divi's Laboratories (10.81%).
Rubicon Research Financials
Rubicon Research Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 963.57 | 948.6 |
| 10 | 964.77 | 948.98 |
| 20 | 927.2 | 927.48 |
| 50 | 836.95 | 863.08 |
| 100 | 767.5 | 791.78 |
| 200 | 505.49 | 0 |
Rubicon Research Share Holding Pattern
In the latest quarter, Rubicon Research saw a drop in promoter holding to 59.86%, while DII stake increased to 10.02%, FII holding fell to 7.54%, and public shareholding unchanged at 22.57% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Rubicon Research Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 1,36,235 | 0.84 | 10.53 |
* Excluding Index & Arbitrage Funds
Rubicon Research Corporate Actions
Date Time | Announcement |
|---|---|
| May 16, 2026, 03:23 AM IST IST | Rubicon Research - Announcement under Regulation 30 (LODR)-Monitoring Agency Report |
| May 01, 2026, 04:33 AM IST IST | Rubicon Research - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, |
| Apr 27, 2026, 07:55 PM IST IST | Rubicon Research - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A |
| Apr 22, 2026, 04:02 PM IST IST | Rubicon Research - Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requ |
| Apr 15, 2026, 10:56 PM IST IST | Rubicon Research - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
About Rubicon Research
Rubicon Research Ltd. is a Public Limited Listed company incorporated on 06/05/1999 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is U73100MH1999PLC119744 and registration number is 119744. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 1073.84 Cr. and Equity Capital is Rs. 15.41 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressMedOne House, B-75, Road No. 33, Wagle Estate, Thane Maharashtra 400604
- Contact
Management
- Ms. Pratibha PilgaonkarManaging Director
- Mr. Parag Suganchand SanchetiExecutive Director & CEO
- Mr. Venkat ChangavalliChairperson & Independent Director
- Mr. Varun TalukdarNon Executive Director
- Mr. Shantanu RastogiNon Executive Director
- Mr. Anand AgarwalNon Executive Director
- Mr. Kumarapuram Gopalakrishnan AnanthakrishnanIndependent Director
- Mr. Milind Anil PatilIndependent Director
FAQs on Rubicon Research Share Price
What is the share price of Rubicon Research?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Rubicon Research is ₹962.55 as on May 15, 2026.
What kind of stock is Rubicon Research?
The Rubicon Research is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Rubicon Research?
The market cap of Rubicon Research is ₹15,890.94 Cr as on May 15, 2026.
What are today's High and Low prices of Rubicon Research?
Today’s highest and lowest price of Rubicon Research are ₹981.25 and ₹954.55.
What are the 52 Week High and 52 Week Low of Rubicon Research?
The 52-week high/low is the highest and lowest price at which Rubicon Research stock has traded in the past 52-week or nearly a year. The 52-week high of Rubicon Research is ₹1,019.10 and 52-week low of Rubicon Research is ₹571.00 as on May 15, 2026.
How has the Rubicon Research performed historically in terms of returns?
The Rubicon Research has shown returns of 0.73% over the past day, 16.74% for the past month, 21.29% over 3 months, 53.41% over 1 year, 15.33% across 3 years, and 8.94% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Rubicon Research?
P/E ratio of and PB ratio of Rubicon Research are 77.07 and 22.03 on May 15, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse